(Q39802073)
Statements
Modulation of HER3 is a marker of dynamic cell signaling in ovarian cancer: implications for pertuzumab sensitivity (English)
Yoko Nagumo
Dana Faratian
Peter Mullen
Max Hasmann
8 September 2009
scientific article